MINISO Stock Analyst Target Cut to $19.62; 66% Upside Remains on Table

MINISO Group (MNSO) saw its average analyst price target cut to $19.62 on July 11, down from $19.91. Despite the revision, 18 of 19 covering analysts maintain a Buy rating, and the new target still implies 66% upside from the prior close. Forecasts range from $14 to $22.86 per share across the 13 analysts surveyed.

Why the target fell but bulls stayed put

The analyst consensus shifted downward, yet the Buy rating persisted. This signals analysts see value even at lower expectations. The $19.62 target reflects a more cautious near-term view, but the wide range of forecasts (from $14 to $22.86) shows disagreement on the stock’s true fair value. The 66% upside calculation assumes the stock trades near its July 10 closing price.

Meyka grade and technical backdrop

MNSO carries a Meyka grade of B with a Hold recommendation. The 12-month Meyka forecast stands at $19.29, nearly aligned with the analyst consensus of $19.62. Meyka’s DCF and ROE scores both hit 5 (Strong Buy), but debt-to-equity concerns pulled the overall grade down. Technical indicators show RSI at 41.80 and ADX at 30.94, signaling a strong downtrend. The stock trades at 12.46x trailing earnings, below its 50-day average of $13.16.

Stock performance and valuation context

MNSO closed at $11.79 on the data date, up 2.79% that day but down 37.23% year-to-date. The stock trades well below its 52-week high of $26.74 and near its low of $11.12. At current levels, the P/E ratio of 12.46 sits below the sector median, and the dividend yield stands at 5.65%, offering income to patient holders. The company’s market cap is $3.59 billion.

What this means for investors

The analyst cut reflects caution on near-term growth, but the 66% upside and persistent Buy consensus suggest the market has priced in pessimism. Meyka’s B grade aligns with this view: the fundamentals support a hold, not a sell. Investors should watch the August 20 earnings call for signs of stabilization in the lifestyle retail segment and clarity on international expansion.

Final Thoughts

MINISO’s analyst target fell but Buy ratings held firm, signaling a floor beneath the stock. With Meyka grading it B and the consensus target at $19.62 versus current trading near $11.79, the risk-reward favors patient holders, though near-term volatility remains high.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.